Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS

NCT01702987 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Myopathy
HMG COA Reductase Inhibitor Adverse Reaction
Hypercholesterolemia

Interventions

DIETARY_SUPPLEMENT: ubiquinol
DIETARY_SUPPLEMENT: placebo
DRUG: statin

Sponsor

Beth Israel Deaconess Medical Center